Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Here's what a handful of investing professionals say about the market's rapid recovery - and the fragile Middle East truce.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
The stock market was mixed, but the S&P 500 held its 50-day line. Tesla hit a high while Palantir is near a buy point.
This thriving AI business has been an unbelievably successful investment in recent years.
Shares saw their first record close since December 2024, helping support the continued reign of the "Magnificent Seven."
Shares of cannabis stocks continued their rally Tuesday, after President Donald Trump a day earlier said he was "very strongly" weighing an executive order...
Solid Biosciences stock rises after Duchenne added to newborn screening list
DBV Technologies stock soars after positive Phase 3 trial results
Investors can expect asset write-downs and new plans from auto makers that leaned a little too hard into the trend. Curiously, that shouldn't be a headwind...
E.W. Scripps stock falls after board rejects Sinclair's $7 per share offer
Google's new deal could serve as a blueprint for the energy industry.
Nvidia stock has been hit by worries over an artificial-intelligence bubble but UBS analysts think the concerns are overblown.
Growth may mellow out, but the long-term prospects remain strong.